Journal of Hematology and Oncology (JHO) is a scholarly journal dedicated to publishing research in the field of Medicine. BioMed Central is the publisher of this esteemed journal. The P-ISSN assigned to Journal of Hematology and Oncology is 1756-8722 and its abbreviated form is J Hematol Oncol.
Journal of Hematology & Oncology is an open access journal that publishes top-quality research encompassing all aspects of hematology and oncology. The journal also publishes reviews and research highlights on "hot topics" from leading experts in the field.
Hematology and oncology are closely intertwined and rapidly evolving fields. More physician scientists performing laboratory-based research are rapidly bringing research in hematology and oncology from bench to bedside. Journal of Hematology & Oncology aims to meet the demand for a journal dedicated to publishing discovery from both of these fields.
| Journal title | Journal of Hematology and Oncology (JHO) |
| Abbreviation | J Hematol Oncol |
| Print ISSN | 1756-8722 |
| Publisher Name | BioMed Central |
| Editor-in-chief | Prof Delong Liu, New York Medical College, USA |
| Subject Category | Medicine |
Journal of Hematology and Oncology Abbreviation : ISO Journal abbreviation refers to the shortened form or acronym used to represent the full title of a scholarly journal. The ISO4 Abbreviation of Journal of Hematology and Oncology Journal is J Hematol Oncol.
The Ranking of Journal of Hematology and Oncology in 2026 is 194. Ranking systems aim to provide an indication of a journal's quality, influence, and prestige within a specific field or discipline.
The Impact Factor of Journal of Hematology and Oncology in 2026 is 23.1. it is all calculated by Clarivate, which means how many times a particular citation has been published in the past two years.
The SCImago of Journal of Hematology and Oncology in 2026 is 6.046. It is measured by the number of citations which are made by the particular journals, and the journal from where the citations arrived from.
The H-Index of Journal of Hematology and Oncology in 2026 is 122. The H-index is calculated on how many times a particular author is cited and the number of published papers that a particular author has.
The Quartile of Journal of Hematology and Oncology is Q1. A quartile has three points, which are the upper quartile, median, and lower quartile. The main motive of the quartile is to calculate the interquartile range, that resembles the changes across the median.
The Journal of Hematology and Oncology is indexed in (Indexing details)
| PubMed | Scopus | Web of Science | UGC | Embase | DOAJ |
|---|---|---|---|---|---|
| ✅ | ✅ | ❌ | ✅ | ✅ | ✅ |
Indexing services aim to make it easier for researchers, scholars, and readers to discover and access articles from various journals within a specific field or discipline.
| Abbreviation | J Hematol Oncol |
| Access type | Open Access |
| Impact Factor | 23.1 |
| SJR | 6.046 |
| SNIP | 4.045 |
| Ranking | 194 |
| CiteScore | 38.4 |
| H-Index | 122 |
The Editor-in-chief of Journal of Hematology and Oncology is Prof Delong Liu, New York Medical College, USA
Journal of Hematology and Oncology Processing/Submission Fee : Article submission/Processing fees (APC), also known as manuscript Publication fees or processing fees (APC), are charged by journals to authors for submitting/publishing their research papers/article.
The APC/Submission (Publication) Fee of Journal of Hematology and Oncology is 3690 EUR, 4390 USD, 3090 GBP
Journal of Hematology and Oncology Call for paper : Journal of Hematology and Oncology invites original research contributions for consideration of publication in Journal of Hematology and Oncology journal.
Journal seeking submissions in the broad areas of Medicine that align with journal's focus on Medicine.
for details about call for paper please visit to the official website of the journal to check the details about call for papers.
Publishing in Journal of Hematology and Oncology involves the following steps:
Yes, the Journal of Hematology and Oncology journal is indexed in PubMed.
Yes, the Journal of Hematology and Oncology journal is indexed in Scopus.
Yes, the Journal of Hematology and Oncology journal is indexed in UGC.
No, the Journal of Hematology and Oncology journal is not indexed in Index copernicus.
No, Journal of Hematology and Oncology journal is not a predatory journal.
The Impact Factor of the Journal of Hematology and Oncology is 23.1.
The Ranking of the Journal of Hematology and Oncology is 194.
Yes the Journal of Hematology and Oncology (JHO) journal is a peer-reviewed journal.
Yes the Journal of Hematology and Oncology journal is a peer-reviewed journal and good to publish your paper.
Journal of Hematology and Oncology (JHO) is a scholarly journal dedicated to publishing research in the field of Medicine. BioMed Central is the publisher of this esteemed journal.
Yes, Journal of Hematology and Oncology is a open access journal.